1 hour ago
AbCellera (ABCL) Stock Surges 6% on Menopause Treatment Phase 2 Data Reveal
AbCellera (ABCL) stock rose 6% after Q2 earnings and announcement of Phase 2 data for non-hormonal menopause treatment ABCL635 coming August 10, 2026.
The post AbCellera (ABCL) Stock Surges 6% on Menopause Treatment Phase 2 Data Reveal appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Tempus AI (TEM) Stock Soars 11% on Groundbreaking Cancer AI Study and Quarterly...
- 1 hour ago
Uber (UBER) Stock Surges on Q2 Earnings Beat: Is the Rally Sustainable?
- 2 hours ago
QuantumScape (QS) Stock Surges 16.5% This Week Despite Lack of News
- 2 hours ago
Westwater Resources (WWR) Stock Soars 88% on $25M Federal Financing Deal
- 2 hours ago
Berkshire Hathaway (BRK.A) Stock Surges as Q2 Earnings Double Year-Over-Year